Works matching IS 18607179 AND DT 2023 AND VI 18 AND IP 2
Results: 8
Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023).
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200703
- By:
- Publication type:
- Article
Imaging of K<sub>Ca</sub>3.1 Channels in Tumor Cells with PET and Small‐Molecule Fluorescent Probes.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200551
- By:
- Publication type:
- Article
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200548
- By:
- Publication type:
- Article
Modifications to a Biphenolic Antibacterial Compound: Activity against ESKAPE Pathogens.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200521
- By:
- Publication type:
- Article
Imidazolylpyrrolone‐Based Small Molecules as Anticancer Agents for Renal Cell Carcinoma.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200519
- By:
- Publication type:
- Article
Inhibition of Amyloid Protein Aggregation Using Selected Peptidomimetics.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200499
- By:
- Publication type:
- Article
How Structure–Function Relationships of 1,4‐Naphthoquinones Combat Antimicrobial Resistance in Multidrug‐Resistant (MDR) Pathogens.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200471
- By:
- Publication type:
- Article
Erlotinib‐Modified BODIPY Photosensitizers for Targeted Photodynamic Therapy.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200439
- By:
- Publication type:
- Article